JPMORGAN CHASE & CO - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$2,006
-34.2%
993
-3.9%
0.00%
Q2 2023$3,047
-95.5%
1,033
-96.2%
0.00%
Q1 2023$67,000
+102976.9%
27,038
+31.9%
0.00%
Q4 2022$65
-99.9%
20,496
-2.6%
0.00%
Q3 2022$62,000
+3.3%
21,044
+6.6%
0.00%
Q2 2022$60,000
-77.2%
19,739
+1.2%
0.00%
Q1 2022$263,000
+28.9%
19,500
+24.8%
0.00%
Q4 2021$204,000
-76.7%
15,631
-83.3%
0.00%
Q3 2021$877,000
+590.6%
93,495
+654.5%
0.00%
Q2 2021$127,000
-43.6%
12,391
+1.3%
0.00%
Q1 2021$225,000
-79.0%
12,228
-60.9%
0.00%
Q4 2020$1,072,00031,3050.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders